Patient recruitment at the speed of science

Learn how Sermonix Pharmaceuticals partnered with Tempus and its TIME network of clinical sites to accelerate patient recruitment for a phase 2 study.

Sep 20, 2022
Life Sciences
Article
Sibel Blau, MDPresident and CEO, Quality Cancer Care Alliance Network, Medical Director, Northwest Medical Specialties
Matthew Cooney, MDVice President, Therapeutic Development, Tempus